Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nanoformed TargTex oncology drug candidate TTX101 receives FDA Orphan Drug Designation

Press release Nanoform Finland Plc October 19, 2023 12:15 Finnish time / 11:15 Swedish time Nanoformed TargTex oncology drug candidate TTX101 receives FDA Orphan Drug Designation Helsinki, Finland – Nanoform Finland Plc (Nasdaq Helsinki NANOFH; Nasdaq Stockholm NANOFS), an innovative nanoparticle medicine enabling company, today announced its customer TargTex S.A. has been granted Orphan Drug Designation by the FDA for its nanoformed drug candidate TTX101 to be used in patients with malignant gliomas.  The orphan drug designation follows the generation of a preclinical rodent

CapMan to publish its 1–9 2023 Interim Report on Thursday 26 October 2023

CapMan Plc press release                              19 October 2023 at 12:15 p.m. EEST CapMan to publish its 1–9 2023 Interim Report on Thursday 26 October 2023 CapMan will publish its interim report for the period 1 January–30 September 2023 on Thursday 26 October 2023 around 8.00 a.m. EEST as a stock exchange release. The company’s CEO Pia Kåll will present the results for the review period to analysts, investors and the media over a live webcast press conference starting at 9.30 a.m. EEST available at https://capman.videosync.fi/2023-q3-results. The result presentation is

Redwood Pharma to participate in the BIO-Europe partnering conference in Munich

Stockholm, 19 October 2023. Redwood Pharma AB (publ) announces today that the company will participate in BIO-Europe, the life science industry's largest investor and partnering meeting, in November 2023.Redwood Pharma CEO Martin Vidaeus will attend BIO-Europe that will be held in Munich, Germany, between November 6-8. BIO-Europe is Europe's leading partnering event with over 5,500 participants representing 60 countries and over 2,200 companies. The conference creates a unique opportunity for Redwood Pharma to engage in discussions with potential partners. "After the summer, we received

Upgraded Voi e-scooters arrive in Oxford

Above: The V5 Scooter Credit: Voi Oxford, 19 October 2023: Oxford’s provider of shared e-scooters, Voi, has launched its latest e-scooter across the city. The new model offers upgraded features for a better user experience to encourage even more people to get around the city in an environmentally friendly way. The new top-of-the-range hi-tech ‘Voiager 5’ or ‘V5’ scooters have a bigger front wheel, with a shock absorption system and deep tyre tread for increased safety and smoother ride on bumpy road surfaces. Following feedback from riders, the handlebars and

Pihlajalinna Plc publishes Interim Report for January 1–September 30, 2023 on Friday, 3 November, 2023

Pihlajalinna Plc                     Investor News                       19 October 2023 at 12:00Pihlajalinna Plc publishes Interim Report for January 1–September 30, 2023 on Friday, 3 November, 2023 Pihlajalinna Plc will publish the Interim Report for the period of January 1–September 30, 2023 on Friday, 3 November, 2023 at approximately 8.00 a.m. The release will be available on the company website . Live webcast for analysts, investors and mediaPihlajalinna will organize a live webcast meeting for

Paindrainer AB and IHE publish US Health Economic Study highlighting excessive cost to society and payers for chronic pain

MEDICON VILLAGE, LUND, SWEDEN – Paindrainer AB, in collaboration with the Institute of Health Economics (IHE), has undertaken and unveiled considerable costs in a health economic study. The study underscores the substantial impact of chronic pain on the cost to both society, health organisations and payers. In addition, it also sheds light on the potential for improvement through the utilization of a digital self-management tool like Paindrainer®.The main outcomes of the study are: · Chronic pain is associated with a significant burden, including a low quality-of-life, significant

Disguising Your Pet for Halloween: A Bad Idea!

As the spookiest day of the year approaches, the excitement surrounding Halloween continues to grow. While the temptation to dress up our beloved pets in cute and quirky costumes is undeniable, Agria Petinsure is here to remind you that costumes can pose serious health and wellbeing risks to your dogs. Here are three compelling reasons why you should reconsider dressing up your four-legged friends this Halloween. Uncomfortable Costumes:  Most pet costumes are designed in standard sizes that may not account for your specific pet's body shape. This can lead to discomfort,

Official opening ceremonies at the new Peikko factory in Johor Bahru, Malaysia

Peikko Group Corporation, a leading global supplier of concrete connections and composite structures, celebrated the grand opening of its newest factory in Johor Bahru, Malaysia on the 18th of October 2023. Peikko was honored to have distinguished guests, Mr. Sami Leino, Ambassador of Finland to Malaysia and Brunei and Mr. Pekka Laitinen, Head of Business Finland APAC, to perform the official opening of the factory. In addition, more than 80 other important stakeholders representing customers, suppliers, partners, and authorities attended the opening ceremonies. The new

Atea Sweden signs new frame agreement with Swedish Transport Administration

Atea Sweden has today entered a new frame agreement with the Swedish Transport Administration (Trafikverket) for the delivery of software and related services.  The term of the agreement is two years, with a possible extension of an additional two years.  The frame agreement will commence on January 1, 2024.  Estimated sales under this frame agreement are SEK 240 million per year. Atea Sweden is the sole supplier under this frame agreement.  The new frame agreement will replace a previous frame agreement with Trafikverket on which Atea was also the sole supplier.  “The market for

Peptonic receives first order from Windsor Pharmaceuticals in Central America

Peptonic Medical AB (publ) today announced that it has received its first order in Central America from Windsor Pharmaceuticals."It is gratifying that Windsor now is ready to launch our products in El Salvador and Panama. We see great potential in this region and expect launches in more countries next year," said Erik Sundquist, CEO of Peptonic. The order from Windsor Pharmaceuticals is for Peptonic's vaginal self-tests VagiVital AL Sense, for detecting amniotic fluid leakage during pregnancy, and VagiVital VS Sense Pro for diagnosing bacterial vaginosis. Both products are aimed at

BioStock: Invent Medic strengthens its presence in Germany with a new distributor

Invent Medic has experienced a good momentum in its sales growth so far this year. At the same time, not all markets have developed as expected, with the company singling out Germany as a country where it has not been completely satisfied. The company is now making a renewed effort in the country by appointing Kessel Medintim their new distributor. BioStock reached out to CEO Anna Lindström for her comment on the latest news.Read the full article at biostock.se: https://www.biostock.se/en/2023/10/invent-medic-strengthens-its-presence-in-germany-with-a-new-distributor/ This is a press

Vattenfall to present interim report for January-September 2023 on October 26

Vattenfall's interim report for January to September 2023 will be published on Thursday October 26 at 08.00 CEST on group.vattenfall.com. A live studio broadcast for analysts and media will start at 09.30 CEST.Vattenfall’s President and CEO Anna Borg and CFO Kerstin Ahlfont will present the results together with Senior Vice President Strategic Development Andreas Regnell. The presentation and following Q&A session will be held in English. Link: Vattenfall Q3 2023 

Elos Medtech publishes prospectus for the rights issue and updates timetable

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE FURTHER REGISTRATION MEASURES. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE “IMPORTANT INFORMATION” AT THE END OF THE PRESS RELEASE. Elos Medtech publishes prospectus for the rights issue and updates timetable The prospectus for the rights issue of shares of series B  in Elos

ChromoGenics Launches New Website for ConverLight® Dynamic

As part of ChromoGenics' expansion strategy, the company has now launched an entirely new website for its leading innovation, ConverLight® Dynamic. The website will further strengthen their sustainability profile and open up opportunities for quicker entry into new markets. On Thursday, 19th October 2023, ChromoGenics unveiled its new website focusing on its market-leading product, ConverLight® Dynamic. The aim is to meet the growing interest in electrochromic glass solutions, which innovatively address today's challenges in sustainable construction, energy consumption, and indoor

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 173 - 19 OCTOBER 2023 In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 112/23 and 113/23.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Nomination Committee appointed for Instalco AB:s Annual General Meeting 2024

In accordance with the principles adopted by the general meeting in Instalco AB held on 6 May 2021, the Nomination Committee shall be comprised of the Chairman of the Board of Directors and three members appointed by the three shareholders with the largest number of votes in the company. If either of the shareholders with the largest number of votes waives their right to appoint a member, the shareholder with the next largest shareholding shall be offered the opportunity to appoint a member.The Nomination Committee ahead of the 2024 AGM comprises the following members: • Lennart Francke (

Nokian Tyres launches a test-winning VF tractor tire and a VF flotation tire for efficient farming at Agritechnica 2023 in November

Nokian Tyres Flexforce® VF is a unique new tire technology that enables more efficient agricultural work by creating an XXL-sized ground contact and by reducing loss of power. The first tractor tire utilizing this technology is Nokian Tyres Soil King VF, which has already proven to be ahead of competition in third-party tests. A new flotation tire for high-capacity tankers and trailers, Nokian Tyres Float King VF, complements the Flexforce VF range. Nokian Tyres is proud to present the new tires as well as the existing range of special tires at the agricultural trade fair Agritechnica 2023 in

Invitation to presentation of Prevas’ interim report January-September 2023

Prevas will publish the interim report for January-September 2023 on Thursday, October 26, at 08:30. On the same day at 09.00 a.m. a press and analyst presentation will be held which can be followed via webcast and telephone conference. The presentation is given in English by Magnus Welén (CEO) and Helena Burström (CFO) from Prevas AB. If you wish to participate via webcast, please use the link below. Via the webcast you can ask written questions. Here you can participate via the webcast.  If you wish to participate via

United Bankers’ alternative investment fund and Ramboll Finland Oy signed a major cooperation agreement to promote renewable energy projects

United Bankers Plc PRESS RELEASE 19 October 2023 at 10:00 EEST   United Bankers’ alternative investment fund and Ramboll Finland Oy signed a major cooperation agreement to promote renewable energy projects United Bankers' UB Renewable Energy Fund (AIF) has signed a large-scale cooperation agreement with Ramboll Finland Oy to develop a portfolio of renewable energy projects. Through the cooperation, UB Renewable Energy will have access to Ramboll’s technical, planning and environmental expertise at all stages of renewable energy project development. "Ramboll represents the

The last day of trading in warrants of series TO 2 is on the 24th of October 2023

The 24th of October 2023 is the last day of trading in warrants of series TO 2, which were issued in connection with Carbiotix AB's ("Carbiotix" or the "Company") preferential rights issue of units that was carried out in the spring of 2023. The exercise period runs until the 26th of October 2023.In connection with the Company's preferential rights issue of units carried out in 2023, 3,190,188 warrants of series TO 2 were issued. Holders of TO 2 have the right to subscribe for one (1) new share in Carbiotix at a price of SEK 1.50 per share during the exercise period, which runs from October

HC Andersen Capital Events 19/10: Meet the management in OrderYoYo

HC Andersen Capital is today hosting a digital event where you can meet and ask questions directly to the management. It is free for all to attend.In OrderYOYO’s Q3 2023 results, the company continued this year's strong momentum with 38% ARR growth and 31% revenue growth. The momentum was further highlighted by the fourth upward revision of its 2023 guidance this year on both the top line and bottom line. This is despite continued challenging market conditions. In addition to strong revenue growth, earnings focus continues with a positive EBITDA result of DKK 16.5m in the first nine

Ellos Group brings forward the publication of the interim report for the third quarter

Press release, Borås, 19 October 2023 Ellos Group AB (publ) has decided to bring forward the publication of the interim report for the third quarter 2023 to October 26, 2023. Previously, the date for publication of the report was set to November 16, 2023. The release date has been brought forward because the report will be completed earlier than expected. The board therefore sees no reason to delay the report’s publication. For more information:Johan Stigson, CFO, Telephone. +46 (0)33 16 08 05. About ELLOS GROUP The Ellos Group, which includes the e-stores Ellos, Jotex,

Carbonhand sales take off in Europe's largest market

Sales of the strength-enhancing glove Carbonhand[®] have taken off in the German market, where it is estimated that over one million people would be helped by Carbonhand. So far this year, more than four times as many Carbonhand systems have been ordered for Germany compared to the same period last year. Germany is Europe's largest market in terms of population and over 8.7 million people have disabilities of the types Carbonhand is designed for. External analyses show that, conservatively, over 1 million of these people could be helped by Carbonhand to cope better with everyday

There are no items matching the current filter
There are no more items matching the current filter
Back to top